Biotech Investment News: Major Pharmaceutical Deals of Astellas Pharma (2015–2025)
Strategic Review: Investing in Marketed Products and Next-Gen Modalities Astellas Pharma has executed a series of acquisitions and collaborations from 2015 to 2025 focused on immuno-oncology, ophthalmology, neurology, and gene therapy. K...
